Endralazine: Difference between revisions

Endralazine
Clinical data
ATC code	C02DB03 (WHO) ;
Pharmacokinetic data
Bioavailability	C14H15N5O
Identifiers
PubChem CID	47608;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass	269.3018

Revision as of 02:15, 9 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Endralazine is an antihypertensive.

@@ Line 26: / Line 26: @@
 {{CMG}}
-{{EH}}
 '''Endralazine''' is an [[antihypertensive]].

v t e Antihypertensives (C02) and diuretics (C03)
Sympatholytic agents	Template:Navbox subgroup
Vasodilators	Diazoxide • hydrazinophthalazine (Hydralazine, Dihydralazine, Endralazine, Cadralazine) • Minoxidil • Nitroprusside • Phentolamine
Other antihypertensives	serotonin antagonist (Ketanserin) • endothelin receptor antagonist (Bosentan, Ambrisentan, Sitaxsentan) • MAOI (Pargyline) • THI (Metirosine)
Diuretics	Template:Navbox subgroup

Clinical data
ATC code	C02DB03 (WHO)
Pharmacokinetic data
Bioavailability	C14H15N5O
Identifiers
PubChem CID	47608
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass	269.3018